Introduction {#s1}
============

Research on quality in health care has built a sizeable knowledge base over the past three decades. Evidence on the effectiveness of organizational quality management and improvement systems has emerged more recently \[[@MZU025C1]--[@MZU025C4]\]. This recent research has addressed several questions. Do quality improvement activities lead to better quality of care? Which quality improvement tools are most effective? How can various quality tools be integrated into a sensitive and effective quality and safety improvement programme? What factors impact on the implementation of quality strategies at hospital level? \[[@MZU025C5], [@MZU025C6]\].

Recent European Union (EU) projects, such as the 'Methods of Assessing Responses to Quality Improvement Strategies' (MARQUIS) and the 'European Research Network on Quality Management in Health Care' (ENQUAL), have attempted to measure the effects of a variety of quality strategies in European hospitals in order to provide information that payers could use as they contract for the care of patients moving across borders. This prior research has had limitations including an incomplete conceptualization of antecedents and effects of quality management systems, methodological weaknesses in measurement strategies and limited use of data on patient outcomes in the evaluation of the effectiveness of these strategies \[[@MZU025C7]--[@MZU025C12]\].

This paper provides an overview of the conceptual framework and methodology of the recently completed DUQuE project (Deepening our Understanding of Quality Improvement in Europe) funded by the European Commission 7th Framework Programme. At its start, the goal of this project was to evaluate the extent to which organizational quality improvement systems, organizational culture, professional involvement and patient involvement in quality management are related to the quality of hospital care, assessed in terms of clinical effectiveness, patient safety and patient experience in a large and diverse sample of European hospitals.

DUQuE had the following specific objectives: To develop and validate an index to assess the implementation of quality management systems across European hospitals (addressed in three papers by Wagner *et al*. \[[@MZU025C13]--[@MZU025C15]\]).To investigate associations between the maturity of quality management systems and measures of organizational culture, professional engagement and patient involvement in quality management, including board involvement on quality and its association with quality management systems (addressed by Botje *et al*. \[[@MZU025C16]\]), the relationship between organizational culture and structure and quality management systems (addressed by Wagner *et al*. \[[@MZU025C17]\]) and the development and validation of the measures for evaluation of clinical management by physicians and nurses (addressed by Plochg *et al*. \[[@MZU025C18]\]).To investigate associations between the maturity of quality management systems and patient level measures (PLMs) of clinical effectiveness, patient safety and patient experience including the relationships between quality management systems at hospital and pathway levels (addressed by Wagner *et al*. \[[@MZU025C19]\]), patient safety and evidence based management (addressed by Sunol *et al*. \[[@MZU025C20]\]), and patient involvement in quality management (addressed by Groene *et al*. \[[@MZU025C21]\]).To identify factors influencing the uptake of quality management activities by hospitals, including external pressure as enforced by accreditation, certification or external assessment programmes (addressed by Shaw *et al*. \[[@MZU025C22]\]) and the feasibility of using routine data to compare hospital performance (addressed by Groene *et al*. \[[@MZU025C23]\]).

Conceptual framework {#s2}
====================

The DUQuE study conceptual model was developed by a range of collaborators with a diverse range of disciplinary backgrounds and expertise. The model addresses four levels: hospital, departmental (or pathway) level, patient\'s level and external factors influencing uptake of management decisions (Fig. [1](#MZU025F1){ref-type="fig"}). We hypothesized that hospital level quality management systems would be associated with hospital governance and culture, the degree of professional involvement in management (and more concretely in quality management) and the degree of patient involvement in quality management. We further hypothesized that quality management systems in place to manage specific clinical pathways (sometimes referred to as 'clinical service lines') would be associated with quality management activities at the hospital and pathway level as well as with pathway culture, professionalism and patients\' involvement in quality management. Moreover, we expected quality management systems at both hospital and clinical pathway levels to be associated with patients\' experience, and the safety and clinical effectiveness of patient care for four selected conditions (acute myocardial infarction (AMI), obstetrical deliveries, hip fracture and stroke). These conditions were selected because they cover an important range of types of care, there are evidence-based standards for process of care against which compliance could be assessed and there is demonstrated variability in both compliance with process of care measures and outcomes of care (complications, mortality) that would allow for analysis of associations between these measured constructs. Finally, the conceptual model posited that factors external to these quality management systems would also influence the uptake of quality management activities such as perceived pressure from hospital leadership (chief executive officers and governance boards) and external accreditation, certification and standards programmes that offer audit and feedback regarding quality management and performance. Figure 1DUQuE conceptual framework.

Development of measures {#s3}
=======================

For each construct in the conceptual model, published literature was searched to identify measure sets and instruments used previously. Explicit criteria were used to assess and select measures, including psychometric properties, level of evidence and appropriateness in multi-national studies. Whenever a validated measure, instrument or measure set existed and was deemed appropriate, we requested permission to use it in the DUQuE study. Where we found no existing measures or instruments, new measures were developed. After synthesis, 25 measure domains were defined and included in DUQuE (Table [1](#MZU025TB1){ref-type="table"}). Measures were originally designed in English language and translated to local languages when necessary. Table [2](#MZU025TB2){ref-type="table"} shows the number of cases expected and finally gathered for each instrument designed to operationalize measures according to hospital type. All of the final instruments used are available at the DUQuE\'s website \[[@MZU025C24]\]. Table 1Constructs, measure domains and data collection methods usedConstruct nameMeasure domainMeasure domain definitionData collection methodAdministration systemExternal pressurePerceived external pressureInfluence in hospital management of external factors (accreditation, contracts, press ...)Questionnaire to CEOElectronically administered questionnaireExternal assessmentWhether the hospital has undergone external assessment (accreditation, ISO)Assessment at hospital level performed by an external visitorVisit at hospital level performed by an external visitor. Both, paper and electronically administered audit formsHospital governanceQuality orientation of the management boardIncluding background in quality, time allocated for quality in the meetings, etc.Questionnaire to CEOElectronically administered questionnaireHospital level quality management systems (QMS)Quality Management System Index (QMSI)Index to assess the implementation of quality management system at hospital levelQuestionnaire to hospital quality manager (QM)Electronically administered questionnaireQuality management Compliance Index (QMCI)Measuring compliance with quality management strategies to plan, monitor and improve the quality of careAssessment at hospital level performed by an external visitorBoth paper and electronically administered audit formsClinical Quality Implementation Index (CQII)Index measuring to what extent efforts regarding key clinical quality areas are implemented across the hospitalAssessment at hospital level performed by an external visitorBoth paper and electronically administered audit formsHospital cultureOrganizational culture Competing values framework (CVF)CVF has two dimensions: structure of internal processes within the hospital and orientation of the hospital to the outside worldQuestionnaires to Chair of Board of Trustees, CEO, Medical Director and the highest ranking NurseElectronically administered questionnaireSocial capitalMeasures common values and perceived mutual trust within the management BoardQuestionnaire to CEOElectronically administered questionnaireHospital patient safety cultureSafety Attitude Questionnaire (SAQ): Two dimensions measuring perceptions on patient safety culture in terms of teamwork and safety climateQuestionnaires to leading physicians and nursesElectronically administered questionnaireHospital professional involvementProfessional involvement in managementMeasures leading doctors and nurses involvement in management, administration and budgeting and managing medical and nursing practiceQuestionnaires to leading physicians and nursesElectronically administered questionnairePatient involvement in quality managementPatient involvement in quality at hospital levelThis construct assesses patients\' involvement in setting standards, protocols and quality improvement projects. These constructs used in previous research (Groene, ENQUAL)Questionnaire to hospital quality managerElectronically administered questionnaireClient councilMeasures existence and functioning of client councilQuestionnaire to hospital quality managerElectronically administered questionnaireDepartment quality strategiesSpecialized expertise and responsibility (SER)Measures if specialized expertise and clear responsibilities are in place at pathway levelAssessment at pathway or department settings performed by an external visitorBoth paper and electronically administered audit formsEvidence-based organization of pathways (EBOP)Measures if pathways are organized to deliver existing evidence base careAssessment at pathway or Department settings performed by an external visitorBoth paper and electronically administered audit formsPatient safety strategies (PSS)Measures if most recommended safety strategies are in place at ward levelAssessment at pathway or department settings performed by an external visitorBoth paper and electronically administered audit formsClinical review (CR)Measures if clinical reviews are performed systematicallyAssessment at pathway or department settings performed by an external visitorBoth paper and electronically administered audit formsDepartment pathway culturePathway patient safety cultureSAQ: two dimensions measuring perceptions on patient safety culture in terms of teamwork and safety climateQuestionnaires to physicians and nurses at pathway levelQuestionnaire electronically administeredProfessionalismProfessionalismMeasures professional attitudes towards professionalism and behaviour in their clinical areaQuestionnaires to professionals at pathway levelQuestionnaire electronically administeredPatient involvement in quality managementPatient involvement in quality at departmental levelThis construct assesses patient\'s involvement in setting standards, protocols and quality improvement projects. These constructs used in previous research (Groene, ENQUAL)Questionnaire to manager of care pathways or head of departmentQuestionnaire electronically administeredPatient information strategies in departmentsMeasures if information literature, surveys and other activities are conducted at pathway or department levelAssessment at pathway or department settings performed by an external visitorBoth paper and electronically administered audit formsPatient experienceGeneric patient experienceGeneric measure of patient experience (NORPEQ)Patient surveyPaper-based questionnairePerceived patient involvementMeasures perceived involvement of care (from Commonwealth Fund sicker patients survey)Patient surveyPaper-based questionnaireHospital recommendationMeasure of hospital recommendation (from HCAHPS)Patient surveyPaper-based questionnairePerceived continuity of careMeasures patient-perceived discharge preparation (Health Care Transition Measure)Patient surveyPaper-based questionnairePerceived patients safetyPerceived patients safetyMeasures patients\' perception of possible harm and its managementPatient surveyPaper-based questionnaireClinical effectivenessClinical effectiveness indicators for AMI, stroke, hip fracture and deliveriesA set of clinical process composite indicators based on their high evidence of impacting patients\' outcomesPatient clinical charts\
Administrative hospital dataElectronic data collection sheet Table 2Data collection and response rates in the DUQuE projectType of questionnaireExpected *n* questionnaires per hospital with partial data collectionExpected *n* questionnaires per hospital with comprehensive data collectionTotal questionnaires expectedTotal questionnaires obtainedAverage response rateResponse rate country range^a^Professional questionnaires:10 75998579078--98 A. Chair of the Board of Trustees11 B. Chief executive officer11 C. Chief medical officer11 D. Quality manager11 E. Leading physicians and nurses2020 F. Manager of care pathways or head of department04 G. Professionals at pathway level080 M. Highest ranking nurse in the hospital11Patient questionnaires0120867067507552--90Chart reviews014010 11590828966--100External visits017474100100--100Administrative routine data111881779477--100Total amount2637129 80625 94087%[^2]

The DUQuE project used a variety of measures to assess patient experience including a generic patient experience instrument (NORPEQ), a measure of patient-perceived discharge preparation (Health Care Transition Measure) and a single-item measure for perceived involvement of care and hospital recommendation in a DUQuE patient survey instrument. In addition, clinical indicators to assess key patient processes and outcomes were selected using a multi-step process (Fig. [2](#MZU025F2){ref-type="fig"}) that included a search of peer-reviewed literature and extensive searches of guidelines and other sources (a substantial amount of patient safety literature appears in the so-called 'grey literature' and not in peer-reviewed publications). Figure 2Development process of DUQuE clinical indicators.

Clinical indicators for each of the four clinical conditions included in the study were collected, reviewed and rated based on the level of evidence according to the Oxford Centre of Evidence-Based Medicine \[[@MZU025C25]\] and their previous use in multi-national studies. In the next step, five relevant European scientific societies, five individual key experts with knowledge of the health-care systems in Europe and the eight DUQuE field test coordinators, named country coordinators, took part in a multi-stakeholder panel. Participants assessed the proposed clinical indicators using a rating matrix. Criteria applied to select four to six clinical indicators of process and outcome per condition were: comparability, data availability, data quality across the eight countries participating, relevance in the different EU health-care settings and ability of the PLM to distinguish between hospitals. The country coordinators offered structural and epidemiological information about treatment of each of the four clinical conditions. The final indicators were selected from among those with the highest level of evidence and the best multi-stakeholder panel rating results with previous use of an indicator in clinical cross-national comparisons given special consideration.

In each condition one or two composite measures were developed that combined the selected indicators for the purpose of a global analysis of the condition. Table [3](#MZU025TB3){ref-type="table"} shows the final DUQuE indicator list with the source and level of evidence rating for each. Data from clinical indicators were collected via medical records abstraction using a standardized data collection method. Table 3Clinical indicators and composite measures selected for the DUQuE projectConditionMain clinical indicators usedSource^a^Level of evidenceAcute myocardial infarction (AMI)Fibrinolytic agent administered within 75 min of hospital arrivalAHRQAPrimary percutaneous coronary intervention within 90 minAHRQA/BThrombolytic therapy or primary percutaneous coronary intervention givenSee 1a and 2aSee 1a and 2ªTherapy given on time^b^ Anti-platelet drug prescribed at discharge (ASPRIN)AHRQA Beta blocker prescribed at dischargeAHRQA Medication with statin prescribed at dischargeAHRQA ACE inhibitors prescribed at dischargeAHRQAAppropriate medications: all four of anti-platelet, beta blocker, statin, ACE inhibitor) prescribed at discharge^b^DeliveriesEpidural anaesthesia applied within 1 h after being ordered for vaginal birthsThe Danish Clinical RegistriesDExclusive breastfeeding at dischargeWHODBlood transfusion during intended or realized vaginal birthThe Danish Clinical RegistriesBAcute Caesarean sectionObstetric trauma (with instrumentation)OECDBObstetric trauma (without instrumentation)OECDBMother complication: unplanned C-section, blood transfusion, laceration and instrumentation^b^The Danish Clinical Registries**B**Adverse birth outcome (child)^b^The Danish Clinical Registries**B**Birth with complications^b^The Danish Clinical Registries**B**Hip fractureProphylactic antibiotic treatment given within 1 h prior to surgical incisionRANDAProphylactic thromboembolic treatment received on the same day as admission (within 24 h or on same date when (one or more) times not provided)RANDAEarly mobilization (within 24 h or before next day when (one or more) times not provided)The Danish Clinical RegistriesBIn-hospital surgical waiting time \<48 h \[or 1 day when (one or more\] times not provided)OECDCPercentage of recommended care per case: indicators prophylactic antibiotic treatment within 1 h, prophylactic thromboembolic treatment within 24 h, early mobilization within 24 h, in-hospital surgical waiting time \<48 h = YES)^b^StrokeAdmitted to a specialized stroke unit within 1 day after admissionThe Danish Clinical RegistriesAPlatelet inhibitor treatment within 2 days after admissionThe Danish Clinical RegistriesADiagnostic examination within first 24 h/same day after admission using CT or MRI scanThe Danish Clinical RegistriesDMobilized within 48 h (or 2 days when times are missing) after admission?The Danish Clinical RegistriesC/DAppropriate stroke management. All three applied: Platelet inhibitor treatment within 2 days after admission, Diagnostic examination (CT or MRI) within first 24 h and Mobilized within 48 h^b^[^3][^4]

Design and fieldwork protocol {#s4}
=============================

DUQuE was designed as a multi-level cross-sectional study with data collection in eight countries. Selected countries had to have a sufficient number of hospitals to fulfil sampling criteria, represent varied approaches to financing and organizing health care, have research staff with experience in conducting comprehensive field tests and represent the geographical reach of the EU. Turkey was included because of the status of its EU candidacy at the start of the project. The countries invited to participate in the field test were the Czech Republic, England, France, Germany, Poland, Portugal, Spain and Turkey.

Sampling strategy {#s4a}
-----------------

We aimed to collect data for the assessment of hospital-wide constructs from up to 30 randomly selected hospitals in each of the 8 participating countries (*N*~h~ = 240 hospitals, maximum). In each country, for 12 of these 30 hospitals we carried out comprehensive data collection at pathway and patient levels (*n*~h~ = 96 hospitals, maximum).

General acute care hospitals (public or private, teaching or non-teaching) with a minimum hospital size of 130 beds were considered for inclusion into the study. In addition, for comprehensive data collection, hospitals were required to have a sufficient volume of care to ensure recruitment of 30 patients per condition over a 4-month period (a sample frame of a minimum of 90 patients). Specialty hospitals, hospital units within larger hospitals, and hospitals not providing care for the four clinical conditions of study were excluded from further consideration.

Each country coordinator provided to the Central Project Coordination Team (CPCT) a de-identified hospital list (including all hospitals with more than 130 beds, ownership and teaching status) of each country for sampling purposes. A simple random sample was taken to identify candidate hospitals for comprehensive and partial data collection; this was oversampled to anticipate withdrawal of participants. The sampling strategy proved efficient as the distribution of key characteristics such as number of beds, ownership and teaching status did not differ between country-level samples and national distributions.

Recruitment {#s4b}
-----------

After the preliminary sample of hospitals was selected, each country coordinator formally invited the hospital chief executive officers (CEOs) to participate. A total of 548 hospitals were approached of which 192 agreed to participate. The percentage of hospitals accepting participation ranged from 6.7 to 96.8% between countries. The main reasons of declining to participate were related to time constraints, organizational aspects and the complexity of the study. Data from 188 hospitals in 7 participating countries were included in the final analysis. After significant efforts, hospitals in England were not included partly due to delays in obtaining ethical approval and also extensive difficulty recruiting hospitals.

Data collection {#s4c}
---------------

The CPCT facilitated communication and problem solving during the ongoing field test process. Preparation began in July 2010 and included sampling, recruitment, back and forward translation and piloting of measures, preparation of materials and training hospital coordinators in charge of retrieving data. Data collection began formally in May 2011 and was completed by February 2012. Several coordination actions enabled timely data collection of professional questionnaires, patients\' surveys, charts review, external visits and administrative data (Fig. [3](#MZU025F3){ref-type="fig"}). Figure 3Stages of DUQuE field test.

An information technology platform was created to support central collection of responses to professional questionnaires and data from site visits. Among a subset of 88 hospitals a comprehensive data collection required them to provide administrative data and administer 371 questionnaires including patients, professionals, chart reviews and an external visit (Table [2](#MZU025TB2){ref-type="table"}). The remaining hospitals provided administrative data and administered professional questionnaires to 25 respondents. The overall response rate for the different questionnaires was between 75 and 100% for the assessed measures (Table [2](#MZU025TB2){ref-type="table"}).

Once field period was completed, all data collected was cross-checked by the CPCT to ensure that hospital and respondents' codes matched per country. Data were also checked for any discrepancies, specifically the chart review files. All data sets were merged and transferred to the data analysis team.

Ethical and confidentiality {#s4d}
---------------------------

DUQuE fulfilled the requirements for research projects as described in the 7th framework of EU DG Research \[[@MZU025C26]\]. Data collection in each country complied with confidentiality requirements according to national legislation or standards of practice of that country.

Discussion {#s5}
==========

The DUQuE project has achieved several important advances that are detailed in the papers included in this supplement. First, it is the first large-scale quantitative study exploring across a broad and diverse sample of European hospitals several features of the implementation of hospital quality management systems and their impact on quality and safety. It represents a major advance over previous research by including patient-level processes and outcomes, enabling study of the impact of current quality improvement strategies on patient care and outcomes. Secondly, it made use of a comprehensive conceptual model describing the functioning of hospital quality management systems and supporting a deliberate empirical, quantitative measurement and analytic approach. Thirdly, it succeeded in collecting and linking large amounts of data from hospitals in seven countries including professional surveys (management and baseline), patient surveys, clinical indicators from medical records and administrative data from participating hospitals. Fourthly, the DUQuE coordination structure and protocol including periodic follow-up and feedback to hospital coordinators enabled the project to obtain the active participation of hospitals and high response rates. Finally, the project led to the development of new measures, reported in this supplement, which can be used in future research.

Despite these many achievements, the study has limitations that are worth highlighting. First, the study was not designed or powered to report on the results for each country. We pooled data across countries and addressed heterogeneity in country-level estimates in our statistical modelling using an approach that allowed country-level baselines and effects to vary. Further covariate adjustment included hospital size, ownership and teaching status. A second limitation is that we used a cross-sectional study design. This was considered most appropriate for hypothesis testing in this project because it requires a relatively shorter time commitment and fewer resources to conduct, although ultimately does not allow strong conclusions about causality \[[@MZU025C27]\]. The use of directed-acyclic graphs guided the development of our statistical models, incorporating theory and knowledge derived from previous research findings and this approach helps somewhat in strengthening causal inferences from the project results. A third limitation is related to the sampling strategy. Although a random sampling strategy was used, a generalization to participating countries and hospitals is limited because hospitals volunteered to participate in the project introducing potential self-selection bias. However, our analysis shows substantial variations in the implementation of quality criteria, and outcomes, suggesting that the effect of self-selection may be less problematic. A final limitation is the existence of systematic biases due to self-report and to country differences in data coding. The study relied on self-reported data that may introduce social desirability bias. In many instances, we were able to use other data sources to verify responses, but not for all measures. Measuring clinical practice using clinical record review may introduce systemic biases related to medical record completeness practice variations among countries, but some of this is handled through statistical adjustment for the effects of country, hospital size, ownership and teaching status. In conclusion, while the design is prone to a number of limitations we anticipated potential problems and addressed them in study design and our analytical strategy.

This supplement presents the first set of results from the DUQuE project. It includes quality management indexes conceptualization and development, validation of new measures and results of tests of associations between some of the main constructs. Future publications are intended to address remaining questions and secondary analyses of this very large database. For example, papers addressing the associations between quality management systems and key patient processes and outcomes are planned. In addition to the research publications, the DUQuE project website offers a set of recommendations presented in an appraisal scheme derived from the broader perspective of this investigation and summarized for hospital managers buyers and policy makers who may find it useful as they redesign organization-wide approaches to hospital care to achieve the highest levels of quality and safety \[[@MZU025C24]\].
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